Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Expert conclusions from the 30th ECOG workshop 2021
To address this, healthcare providers often reduce or discontinue these additional medications while closely monitoring blood sugar levels during the transition
People comparing phentermine versus GLP-1 approaches or phentermine versus semaglutide specifically should factor in how each option interacts with existing diabetes management
Long-term weight loss effects of semaglutide in obesity
Patients taking Wegovy should monitor for alarm features that suggest more serious pathology: Unintentional weight loss beyond expected therapeutic weight reduction Difficulty swallowing (dysphagia) Persistent vomiting Evidence of gastrointestinal bleeding (black, tarry stools or blood in vomit) Severe, unrelenting abdominal pain, especially if radiating to the back (which may indicate pancreatitis) Right upper abdominal pain with or without fever/jaundice (which may indicate gallbladder disease) If you experience these symptoms whilst taking Wegovy, it is essential to contact your GP promptly for clinical assessment
